A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b
Nuvation Bio Inc.
Nuvation Bio Inc.
Hoffmann-La Roche
EpicentRx, Inc.
National Cancer Institute (NCI)
Taproot Health
H. Lee Moffitt Cancer Center and Research Institute
Novartis
Stanford University